146 related articles for article (PubMed ID: 20932276)
1. LATS2 is de-methylated and overexpressed in nasopharyngeal carcinoma and predicts poor prognosis.
Zhang Y; Hu CF; Chen J; Yan LX; Zeng YX; Shao JY
BMC Cancer; 2010 Oct; 10():538. PubMed ID: 20932276
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma.
Sun GG; Zhang J; Ma XB; Wang YD; Cheng YJ; Hu WN
Pathol Oncol Res; 2015 Apr; 21(2):283-91. PubMed ID: 25060857
[TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.
Wang TT; Chen ZZ; Xie P; Zhang WJ; Du MY; Liu YT; Zhu HY; Guo YS
Eur J Pharmacol; 2019 Aug; 856():172352. PubMed ID: 31004603
[TBL] [Abstract][Full Text] [Related]
4. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
5. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
Sadaf ; Habib M; Khan MA; Najm MZ; Mallick MN; Sunita K; Shukla NK; Deo SVS; Husain SA
Gene; 2018 Nov; 676():156-163. PubMed ID: 30010037
[TBL] [Abstract][Full Text] [Related]
7. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma.
Ni H; Zhou Z; Jiang B; Yuan X; Cao X; Huang G; Li Y
Tumour Biol; 2017 Mar; 39(3):1010428317695025. PubMed ID: 28351314
[TBL] [Abstract][Full Text] [Related]
11. [The expression of clock gene CLOCK and its clinical significance in nasopharyngeal carcinoma].
Li XM; Li YY; Zhao CF; Liu LN; He QY; Jiang JQ; Chen Y; Yang MH; Tang YX; Li YX; Jin F
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1255-1263. PubMed ID: 34915633
[No Abstract] [Full Text] [Related]
12. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
13. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
14. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
15. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.
Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G
J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089
[TBL] [Abstract][Full Text] [Related]
16. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W
Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683
[TBL] [Abstract][Full Text] [Related]
17. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z
BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455
[TBL] [Abstract][Full Text] [Related]
18. Hippo pathway and tumoral FOXP3 expression correlate with tumor growth in squamous cell carcinoma of the lung.
Won KY; Kim HK; Kim GY; Song MJ; Lim SJ
Pathol Res Pract; 2020 Jul; 216(7):153003. PubMed ID: 32534707
[TBL] [Abstract][Full Text] [Related]
19. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells.
Zhang W; Zeng Z; Wei F; Chen P; Schmitt DC; Fan S; Guo X; Liang F; Shi L; Liu Z; Zhang Z; Xiang B; Zhou M; Huang D; Tang K; Li X; Xiong W; Tan M; Li G; Li X
FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098
[TBL] [Abstract][Full Text] [Related]
20. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
